Intersect ENT, Inc. Diluted Shares Outstanding (Weighted Average)
Intersect ENT, Inc. reported Diluted Shares Outstanding (Weighted Average) of 33.73 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-04.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2022-05-04
- Intersect ENT, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2022-03-31 was 33.73M shares, a 2.16% increase year-over-year.
- Intersect ENT, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2021-09-30 was 33.35M shares, a 2.01% increase year-over-year.
- Intersect ENT, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2021-06-30 was 33.19M shares, a 1.81% increase year-over-year.
- Intersect ENT, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2021-03-31 was 33.02M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month |
|---|---|---|---|
| 2022-03-31 | 33.73M shares 10-Q · filed 2022-05-04 | ||
| 2021-09-30 | 33.35M shares 10-Q · filed 2021-11-02 | 33.27M shares derived: average of 2 quarters · filed 2021-11-02 | 33.19M shares 10-Q · filed 2021-11-02 |
| 2021-06-30 | 33.19M shares 10-Q · filed 2021-08-06 | 33.10M shares 10-Q · filed 2021-08-06 | |
| 2021-03-31 | 33.02M shares 10-Q · filed 2022-05-04 | ||
| 2020-09-30 | 32.70M shares 10-Q · filed 2021-11-02 | 32.65M shares derived: average of 2 quarters · filed 2021-11-02 | 32.55M shares 10-Q · filed 2021-11-02 |
| 2020-06-30 | 32.59M shares 10-Q · filed 2021-08-06 | 32.48M shares 10-Q · filed 2021-08-06 |